FEDDERSHOL vs SHUKRAPHAR: Stock Comparison

Head-to-head financial and trading comparison between Fedders Holding Limited (FEDDERSHOL) and Shukra Pharmaceuticals Limited (SHUKRAPHAR) in the Cross-Sector Peers sector.

FEDDERSHOL

NSE: FEDDERSHOL
Fedders Holding Limited
₹59.78
1Y Return: +64.91%
52W High: ₹67.22
52W Low: ₹32.33
Annual Volatility: 57.17%
Check FEDDERSHOL Trade Fees →

SHUKRAPHAR

NSE: SHUKRAPHAR
Shukra Pharmaceuticals Limited
₹66.94
1Y Return: +61.61%
52W High: ₹72.58
52W Low: ₹41.42
Annual Volatility: 64.68%
Check SHUKRAPHAR Trade Fees →

Key Metrics Comparison Table

MetricFEDDERSHOLSHUKRAPHAREdge / Winner
Current Market Price (CMP) ₹59.78 ₹66.94 —
1-Year Price Return +64.91% +61.61% FEDDERSHOL (3.30% higher)
52-Week High ₹67.22 ₹72.58 —
52-Week Low ₹32.33 ₹41.42 —
30-Day Annualized Volatility 57.17% 64.68% FEDDERSHOL (Steadier)
30-Day Average Daily Volume 10,597,184 6,592,919 FEDDERSHOL (Higher Liquidity)
Statutory Cost to Trade ₹1 Lakh ₹118.50 ₹118.50 Identical statutory tariff

Frequently Asked Questions

Between FEDDERSHOL and SHUKRAPHAR, which stock gave better returns over the last year?

FEDDERSHOL has outperformed SHUKRAPHAR over the past 12 months with a gain of 64.91% compared to 61.61%.

Which stock is less volatile: FEDDERSHOL or SHUKRAPHAR?

FEDDERSHOL demonstrated lower price volatility (57.17% annualized) compared to SHUKRAPHAR (64.68%). Lower volatility generally indicates steadier price action during market downturns.

What is the statutory cost to buy ₹1,00,000 of FEDDERSHOL vs SHUKRAPHAR?

Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).

Are FEDDERSHOL and SHUKRAPHAR direct sector competitors?

Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.